| DIRECT COMPETITOR COMPARISON | |
| RMDX.OB | Pvt1 | ISEC.OB | Pvt2 | Industry | | Market Cap: | 25.17M | N/A | 4.00M | N/A | 52.74M | | Employees: | 160 | 5501 | 73 | N/A | 70 | | Qtrly Rev Growth (yoy): | -8.00% | N/A | 47.40% | N/A | 18.90% | | Revenue (ttm): | 12.44M | 61.70M1 | 12.16M | N/A | 12.73M | | Gross Margin (ttm): | 2.98% | N/A | 63.00% | N/A | 50.90% | | EBITDA (ttm): | -17.41M | N/A | 1.02M | N/A | -1.76M | | Oper Margins (ttm): | -154.43% | N/A | -9.02% | N/A | -7.52% | | Net Income (ttm): | -24.51M | N/A | -3.54M | N/A | N/A | | EPS (ttm): | -0.141 | N/A | -0.328 | N/A | N/A | | P/E (ttm): | N/A | N/A | N/A | N/A | 26.23 | | PEG (5 yr expected): | N/A | N/A | N/A | N/A | 1.39 | | P/S (ttm): | 2.02 | N/A | 0.33 | N/A | 3.21 |
|
| BIOTECHNOLOGY COMPANIES RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Amgen Inc. | AMGN | 56.79 | 0.00% | 57.48B | 12.39 | | Genentech, Inc. | Private - View Profile | | Biogen Idec Inc. | BIIB | 53.43 | 0.00% | 15.45B | 17.88 | | Genzyme Corp. | GENZ | 48.97 | 0.00% | 13.00B | 27.92 | | Merck Serono S.A. | Private - View Profile | | Chiron Corporation | Private - View Profile | | Gilead Sciences Inc. | GILD | 44.76 | 0.00% | 40.28B | 17.31 | | MedImmune, Inc. | Private - View Profile | | Life Technologies Corporation | LIFE | 52.42 | 0.00% | 9.35B | 1069.80 | | Teva Pharmaceutical Industries Limited | TEVA | 57.20 | 0.00% | 50.39B | 52.33 |
|
| GENERIC DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Sandoz International GmbH | Private - View Profile | | Watson Pharmaceuticals Inc. | WPI | 40.02 | 0.00% | 4.25B | 20.63 | | King Pharmaceuticals Inc. | KG | 12.68 | 0.00% | 3.15B | N/A | | Ranbaxy Laboratories Limited | Private - View Profile | | Mylan, Inc. | MYL | 18.34 | 0.00% | 5.60B | 112.52 | | Pfizer Inc. | PFE | 18.60 | 0.00% | 150.09B | 15.45 | | Johnson & Johnson | JNJ | 64.45 | 0.00% | 177.82B | 14.08 | | GlaxoSmithKline plc | GSK | 41.34 | 0.00% | 104.80B | 13.51 | | Sanofi-Aventis | SNY | 40.28 | 0.00% | 105.18B | N/A | | Novartis AG | NVS | 52.37 | 0.00% | 118.94B | 15.68 |
|
| DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | RHHBY.PK | 43.62 | 0.00% | N/A | N/A | | AstraZeneca plc | AZN | 46.08 | 0.00% | 66.82B | 9.25 | | Abbott Laboratories | ABT | 54.32 | 0.00% | 84.02B | 14.72 | | Bristol-Myers Squibb Co. | BMY | 25.22 | 0.00% | 49.96B | 13.05 |
|
| NEWS ON DIRECT COMPETITORS | |
|
|
|